Retatrutide, a experimental dual stimulator of the GLP-1 receptor and glucose-dependent secreted polypeptide (GIP) receptor , is demonstrating promising outcomes in early patient trials . Recent research https://kingslists.com/story22762486/retatrutide-emerging-research-and-possible-therapeutic-roles